Botanix Pharmaceuticals
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - Industrial WABotanix is a medical dermatology company developing new prescription medicines to treat serious skin diseases, including acne, psoriasis and atopic dermatitis.
Botanix Pharmaceuticals Limited listed on the ASX in July 2016 through a reverse takover of Bone Medical.
Contact Details
D2, 661 Newcastle Street, LEEDERVILLE WA 6007
08 9482 0580
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 111th | Botanix Pharmaceuticals | 117% | 67% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Botanix Pharmaceuticals | $2.1m |
198 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| ECM DEAL: New deal has been added | 22 Jul 2024 |
| NEWS: Tagged in Botanix taps investors for $70m | 21 Jun 2024 |
| NEWS: Tagged in Botanix receives FDA approval for Sofdra | 20 Jun 2024 |
| NEW ROLE: Graeme Morissey, Chief Financial Officer | 26 Mar 2024 |
| ECM DEAL: New deal has been added | 21 Feb 2024 |
| ECM DEAL: New deal has been added | 21 Feb 2024 |
| NEWS: Tagged in Botanix taps investors for $13.5m | 27 Nov 2023 |
| ECM DEAL: New deal has been added | 26 Oct 2023 |
| NEW ROLE: H. McKibbon, | 04 Sep 2023 |
